United Therapeutics Corporation

BOVESPA:U2TH34 Stock Report

Market Cap: R$96.6b

United Therapeutics Future Growth

Future criteria checks 1/6

United Therapeutics is forecast to grow earnings and revenue by 8.1% and 7.7% per annum respectively. EPS is expected to grow by 6.8% per annum. Return on equity is forecast to be 11.8% in 3 years.

Key information

8.1%

Earnings growth rate

6.8%

EPS growth rate

Biotechs earnings growth31.6%
Revenue growth rate7.7%
Future return on equity11.8%
Analyst coverage

Good

Last updated22 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:U2TH34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,3851,2811,4301,69613
12/31/20253,1811,2881,2841,58516
12/31/20242,8821,1931,0831,38715
9/30/20242,7561,1118981,137N/A
6/30/20242,6171,0698781,106N/A
3/31/20242,4981,051752980N/A
12/31/20232,328985748978N/A
9/30/20232,204900764956N/A
6/30/20232,111872674868N/A
3/31/20231,981728722889N/A
12/31/20221,936727664803N/A
9/30/20221,860707679849N/A
6/30/20221,789631652776N/A
3/31/20221,768687673797N/A
12/31/20211,686476477598N/A
9/30/20211,655462487550N/A
6/30/20211,591471560615N/A
3/31/20211,506405574631N/A
12/31/20201,483515696756N/A
9/30/20201,410469660732N/A
6/30/20201,431430597667N/A
3/31/20201,443528564635N/A
12/31/20191,449-104-290-207N/A
9/30/20191,519-92-334-224N/A
6/30/20191,530-118-310-172N/A
3/31/20191,601-150-297-125N/A
12/31/20181,628589594778N/A
9/30/20181,711543447607N/A
6/30/20181,744713N/A628N/A
3/31/20181,744484N/A519N/A
12/31/20171,725418N/A474N/A
9/30/20171,670509N/A723N/A
6/30/20171,632395N/A694N/A
3/31/20171,600657N/A749N/A
12/31/20161,599714N/A644N/A
9/30/20161,595708N/A506N/A
6/30/20161,5731,011N/A484N/A
3/31/20161,507904N/A400N/A
12/31/20151,466652N/A383N/A
9/30/20151,407663N/A448N/A
6/30/20151,351173N/A449N/A
3/31/20151,327186N/A354N/A
12/31/20141,289340N/A355N/A
9/30/20141,231194N/A369N/A
6/30/20141,203282N/A300N/A
3/31/20141,161250N/A438N/A
12/31/20131,117175N/A425N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: U2TH34's forecast earnings growth (8.1% per year) is below the savings rate (10.4%).

Earnings vs Market: U2TH34's earnings (8.1% per year) are forecast to grow slower than the BR market (12.5% per year).

High Growth Earnings: U2TH34's earnings are forecast to grow, but not significantly.

Revenue vs Market: U2TH34's revenue (7.7% per year) is forecast to grow faster than the BR market (7.5% per year).

High Growth Revenue: U2TH34's revenue (7.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: U2TH34's Return on Equity is forecast to be low in 3 years time (11.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y